ArticleAntimicrobial agents and chemotherapy2022

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.

S M Bhavnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.